Skip to main content
AmigoFish

Pharmaceutical Executive Daily: FDA Approves Expanded Indication for Camzyos

From Pharmaceutical Executive · · 2 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Regeneron and Sanofi expand their antibody alliance with four new drug candidates, FDA approves Camzyos for adolescents with obstructive hypertrophic cardiomyopathy, and Michael Abrams questions digital health's savings claims to employers.

Back to Pharmaceutical Executive · Report a problem